Skip to main content
Procter & Gamble Hygiene & Health Care Ltd. logo

Procter & Gamble Hygiene & Health Care Ltd. — Investor Relations & Filings

Ticker · PGHH ISIN · INE179A01014 LEI · 335800NLDWOEI66HEE70 BSE.NS Manufacturing
Open in API
Filings indexed 1,157 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country IN India
Listing BSE.NS PGHH

About Procter & Gamble Hygiene & Health Care Ltd.

https://in.pg.com/

Procter & Gamble Hygiene & Health Care Ltd. specializes in the manufacturing and marketing of branded consumer goods within the health and hygiene categories. The company’s portfolio is anchored by prominent brands such as Whisper and Vicks. Its operations focus on providing feminine care solutions and over-the-counter healthcare products, including cold and flu remedies. Whisper is a market leader in feminine hygiene, while Vicks offers a range of vaporubs, cough drops, and inhalers. The company emphasizes research and development to deliver high-quality products that address consumer needs for wellness and personal care. By utilizing global expertise and local consumer insights, it maintains a strong presence in the market through a commitment to product innovation and brand reliability.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 80% confidence The document is a letter to the BSE and NSE stock exchanges informing them of the schedule for a virtual meeting/connect with analysts and institutional investors. It does not contain financial statements, earnings data, or detailed presentation materials – it simply provides logistical details and confirms no unpublished price‐sensitive information will be discussed. There is no substantive report, transcript, or formal proxy solicitation. Therefore, it is a routine regulatory announcement and falls into the fallback category “Regulatory Filings (RNS).”
2026-06-03 English
We wish to inform you that the management of the Company will be hosting a virtual connect with analysts/ institutional investors on June 16, 2026. Institutional investors/Analysts interested ....
Regulatory Filings Classification · 90% confidence The document is a formal notice to stock exchanges about the schedule of a virtual meeting with analysts and institutional investors. It does not contain financial results, presentations, or detailed financial data, nor does it announce a report publication. It is a routine regulatory announcement (intimation) rather than a financial report, earnings release, or investor presentation. Therefore, it falls under general regulatory announcements.
2026-06-03 English
Resignation of Director/KMP/SMP
Regulatory Filings
2026-05-28 English
Dear Sir, Please find the attached resignation of Chief Financial Officer of the Company.
Board/Management Information Classification · 92% confidence The document is an exchange filing under SEBI Regulation 30 announcing changes in the Board of Directors and Key Managerial Personnel (resignation of the Company Secretary and CFO, re-designation of one director, and appointment of a new Executive Director/CFO). It contains details of appointments and resignations, matching the definition for Board/Management Information rather than a full report, proxy, or other category.
2026-05-28 English
Dear Sir, Board has fixed the Record Date for the purpose of Dividend and AGM.
Regulatory Filings Classification · 86% confidence The document is an exchange listing notice from Procter & Gamble Hygiene and Health Care Limited informing the stock exchanges of the record date for the upcoming 62nd AGM and dividend payment (if approved). It does not present financial results, AGM materials, dividend amounts, or detailed reports—rather it is a routine regulatory compliance announcement. This fits the “Regulatory Filings” category as a general regulatory announcement (fallback for miscellaneous compliance filings).
2026-05-28 English
Press Release
Earnings Release Classification · 90% confidence The document is a press release announcing the audited financial results for the fiscal year ended March 31, 2026, including key highlights such as sales, PAT, quarterly and annual results, and dividend recommendations. This matches the definition of an Earnings Release (ER) as it provides the initial announcement of periodical financial results with key metrics and commentary from management. FY 2026
2026-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.